Program is designed to accelerate access to ExoDx novel liquid biopsy tests for CareFirst members and is first agreement as part of CareFirst’s HealthWorx Program
The partnership with Exosome Diagnostics is part of CareFirst's HealthWorx program, under which the insurance provider works with early-stage companies to accelerate health plan coverage of their products.